© 2020 MJH Life Sciences™ and Modern Retina. All rights reserved.
Cheryl Guttman Krader, BS, Pharm
Articles
KSI-301 for exudative retinal disease showing safety, efficacy, and durability
November 01, 2020
Article
Phase 1b data show improved vision and reduced macular edema in patients, with only 3 loading doses and minimal re-treatments.
Exploring pathogenic cytokines as biomarkers for DME
November 01, 2020
Article
Results support further research investigating transforming growth factor-β-Induced Gene Human Clone 30 (BIGH3).
Choosing a syringe for intravitreal injection
November 01, 2020
Article
Manufacturers are stepping up to design products that will help maximize the safety and efficiency of intravitreal injection.
Aflibercept broadly effective for reducing DR severity in post-hoc analysis
November 01, 2020
Article
The benefit is robust across a variety of demographics and baseline disease characteristics, according to data.